Multiparametric cell cycle analysis by automated microscopy

被引:52
作者
Gasparri, Fabio [1 ]
Cappella, Paolo [1 ]
Galvani, Arturo [1 ]
机构
[1] Nerviano Med Sci, Dept Biol, I-20014 Nerviano, Italy
关键词
cell-based assays; ArrayScan (TM); high-content analysis; cell-cycle; U-2OS;
D O I
10.1177/1087057106289406
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cell cycle analysis using flow cytometry (FC) to measure cellular DNA content is a common procedure in drug mechanism of action studies. Although this technique lends itself readily to cell lines that grow in suspension, adherent cell cultures must be resuspended in a cumbersome and potentially invasive procedure that normally involves trypsinization and mechanical agitation of monolayer cultures. High-content analysis (HCA), an automated microscopy-based technology, is well suited to analysis of monolayer cell cultures but provides intrinsically less accurate determination of cellular DNA content than does FC and thus is not the method of choice for cell cycle analysis. Using Cellomics's ArrayScan (TM) reader, the authors have developed a 4-color multiparametric HCA approach for cell cycle analysis of adherent cells based on detection of DNA content (4,6-diamidino-2-phenylindole [DAPI] fluorescence), together with the known cell cycle markers bromo-2-deoxyuridine (BrdU) incorporation, cyclin B1 expression, and histone H3 (Ser28) phosphorylation within a single cell population. Considering all 4 markers together, a reliable and accurate quantification of cell cycle phases was possible, as compared with flow cytometric analysis. Using this assay, specific cell cycle blocks induced by treatment with thymidine, paclitaxel, or nocodazole as test drugs were easily monitored in adherent cultures of U-2 OS osteosarcoma cells.
引用
收藏
页码:586 / 598
页数:13
相关论文
共 26 条
[1]   EVALUATION OF DOUBLE THYMIDINE BLOCK FOR SYNCHRONIZING MAMMALIAN CELLS AT G1-S BORDER [J].
BOSTOCK, CJ ;
PRESCOTT, DM ;
KIRKPATRICK, JB .
EXPERIMENTAL CELL RESEARCH, 1971, 68 (01) :163-+
[2]   IDENTIFICATION OF DNA-REPLICATING LYMPHOCYTE SUBSETS USING A NEW METHOD TO LABEL THE BROMO-DEOXYURIDINE INCORPORATED INTO THE DNA [J].
CARAYON, P ;
BORD, A .
JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 147 (02) :225-230
[3]   FLOW CYTOMETRIC MEASUREMENT OF TOTAL DNA CONTENT AND INCORPORATED BROMODEOXYURIDINE [J].
DOLBEARE, F ;
GRATZNER, H ;
PALLAVICINI, MG ;
GRAY, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (18) :5573-5577
[4]  
Faretta M, 1998, CYTOMETRY, V31, P53
[5]  
FUCHS DA, 1978, CANCER TREAT REP, V62, P1219
[6]   Quantification of the proliferation index of human dermal fibroblast cultures with the ArrayScanTM high-content screening reader [J].
Gasparri, F ;
Mariani, M ;
Sola, F ;
Galvani, A .
JOURNAL OF BIOMOLECULAR SCREENING, 2004, 9 (03) :232-243
[7]   Mechanism-based target identification and drug discovery in cancer research [J].
Gibbs, JB .
SCIENCE, 2000, 287 (5460) :1969-1973
[8]   Advances in high content screening for drug discovery [J].
Giuliano, KA ;
Haskins, JR ;
Taylor, DL .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2003, 1 (04) :565-577
[9]   S-PHASE DETECTION WITH AN ANTIBODY TO BROMODEOXYURIDINE - ROLE OF DNASE PRETREATMENT [J].
GONCHOROFF, NJ ;
KATZMANN, JA ;
CURRIE, RM ;
EVANS, EL ;
HOUCK, DW ;
KLINE, BC ;
GREIPP, PR ;
LOKEN, MR .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 93 (01) :97-101
[10]  
Gorczyca W, 1997, MODERN PATHOL, V10, P457